SLAMF6 and neoplasm: The B16-F10/mhgp100/SLAMF6+ tumors grew more aggressively: on day 23, the mean tumor volume was 431 mm3 in the SLAMF6-expressing melanomas, compared to 137 mm3 in the non-modified tumors (p=0.04, Student’s t-test) (Figure 2E).